Anti-TNF Therapy and Malignancy – A Critical Review

by Roger B Cohen, Karen A Dittrich
Published 2001-01-01

The contribution of cetuximab in the treatment of recurrent and/or metastatic head and neck cancer

by Mohamedtaki A Tejani, Roger B Cohen, Ranee Mehra
Published 2010-06-01

Immunotherapy for head and neck cancer: latest developments and clinical potential

by Joshua M. Bauml, Roger B. Cohen, Charu Aggarwal
Published 2016-05-01

Immune Checkpoint Inhibitor–Related Cardiovascular Toxicity in Lung Cancer

by Lova Sun, MD, Charu Aggarwal, MD, MPH, Roger B. Cohen, MD
Published 2019-12-01

Impact of telemedicine adoption on accessibility and time to treatment in patients with thoracic malignancies during the COVID-19 pandemic

by Vivek Nimgaonkar, Charu Aggarwal, Abigail T. Berman, Peter Gabriel, Lawrence N. Shulman, John Kucharczuk, Megan Roy, Joshua M. Bauml, Aditi P. Singh, Roger B. Cohen, Corey J. Langer, Melina E. Marmarelis
Published 2021-10-01

Brief Report: Long-Term Follow-Up of Adjuvant Pembrolizumab After Locally Ablative Therapy for Oligometastatic NSCLC

by David J. Cantor, MD, PhD, Christiana Davis, MD, Christine Ciunci, MD, MSCE, Charu Aggarwal, MD, MPH, Tracey Evans, MD, Roger B. Cohen, MD, Joshua M. Bauml, MD, Corey J. Langer, MD
Published 2024-06-01

Treatment of corticosteroid refractory immune checkpoint inhibitor myocarditis with Infliximab: a case series

by Robert S. Zhang, Allison Padegimas, Kathleen M. Murphy, Peter T. Evans, Carli J. Peters, Christopher M. Domenico, Mahesh K. Vidula, Paul J. Mather, Marisa Cevasco, Roger B. Cohen, Joseph R. Carver, Rupal P. O’Quinn
Published 2021-03-01

Phase II Trial of CDX-3379 and Cetuximab in Recurrent/Metastatic, HPV-Negative, Cetuximab-Resistant Head and Neck Cancer

by Julie E. Bauman, Ricklie Julian, Nabil F. Saba, Trisha M. Wise-Draper, Douglas R. Adkins, Paul O’Brien, Mary Jo Fidler, Michael K. Gibson, Umamaheswar Duvvuri, Margo Heath-Chiozzi, Diego Alvarado, Richard Gedrich, Philip Golden, Roger B. Cohen
Published 2022-05-01

Immune Therapy Targeting E6/E7 Oncogenes of Human Paillomavirus Type 6 (HPV-6) Reduces or Eliminates the Need for Surgical Intervention in the Treatment of HPV-6 Associated Recurre...

by Charu Aggarwal, Roger B. Cohen, Matthew P Morrow, Kimberly A Kraynyak, Albert J Sylvester, Jocelyn Cheung, Kelsie Dickerson, Veronique Schulten, Dawson Knoblock, Elisabeth Gillespie, Joshua M. Bauml, Jian Yan, Malissa Diehl, Jean Boyer, Michael Dallas, J. Joseph Kim, David B Weiner, Jeffrey M. Skolnik
Published 2020-01-01

Safety and antitumor activity of the anti-PD-1 antibody pembrolizumab in patients with advanced colorectal carcinoma.

by Bert H O'Neil, John M Wallmark, David Lorente, Elena Elez, Judith Raimbourg, Carlos Gomez-Roca, Samuel Ejadi, Sarina A Piha-Paul, Mark N Stein, Albiruni R Abdul Razak, Katia Dotti, Armando Santoro, Roger B Cohen, Marlena Gould, Sanatan Saraf, Karen Stein, Sae-Won Han
Published 2017-01-01

Death without progression as an endpoint to describe cardiac radiation effects in locally advanced non-small cell lung cancer

by Nikhil Yegya-Raman, Timothy P. Kegelman, Sang Ho Lee, Michael J. Kallan, Kristine N. Kim, Jyotsna Natarajan, Matthew P. Deek, Wei Zou, Shannon E. O'Reilly, Zheng Zhang, William Levin, Keith Cengel, Gary Kao, Roger B. Cohen, Lova L. Sun, Corey J. Langer, Charu Aggarwal, Aditi P. Singh, Rupal O'Quinn, Bonnie Ky, Aditya Apte, Joseph Deasy, Ying Xiao, Abigail T. Berman, Salma K. Jabbour, Steven J. Feigenberg
Published 2023-03-01

Dual checkpoint targeting of B7-H3 and PD-1 with enoblituzumab and pembrolizumab in advanced solid tumors: interim results from a multicenter phase I/II trial

by Xiaoyu Zhang, Anthony M Joshua, Sanjeev Kaul, Scott Antonia, Robert L Ferris, Roger B Cohen, Ezio Bonvini, Jan Baughman, Victoria Atkinson, Charu Aggarwal, Nicholas Vogelzang, Osama Rahma, Mahesh Seetharam, Yanyan Lou, Anthony Tolcher, Fernanda I Arnaldez, Amy Prawira, Ralph Hauke, Vinod Ganju, Andrew Weickhardt, Dan P Zandberg, Arash Rezazadeh Kalebasty, Alex A Adjei, Ariel Birnbaum, Rosetta Cavallo, Linda Peng, Paul A Moore, Stacie M Goldberg, Nehal J Lakhani
Published 2022-04-01

Plasma Genotyping at the Time of Diagnostic Tissue Biopsy Decreases Time-to-Treatment in Patients With Advanced NSCLC—Results From a Prospective Pilot Study

by Jeffrey C. Thompson, MD, MTR, Charu Aggarwal, MD, MPH, Janeline Wong, BS, Vivek Nimgaonkar, BS, Wei-Ting Hwang, PhD, Michelle Andronov, BS, David M. Dibardino, MD, Christoph T. Hutchinson, MD, MA, Kevin C. Ma, MD, Anthony Lanfranco, MD, MS, Edmund Moon, MD, Andrew R. Haas, MD, PhD, Aditi P. Singh, MD, Christine A. Ciunci, MD, MSCE, Melina Marmarelis, MD, MSCE, Christopher D’Avella, MD, Justine V. Cohen, DO, Joshua M. Bauml, MD, Roger B. Cohen, MD, Corey J. Langer, MD, Anil Vachani, MD, MSCE, Erica L. Carpenter, MBA, PhD
Published 2022-04-01